Judge trims US Justice Department lawsuit against Walmart over opioids [Reuters]
Cencora, Inc. (COR)
Last cencora, inc. earnings: 4/30 06:30 am
Check Earnings Report
US:NYSE Investor Relations:
investors.coresite.com/investor-overview
Company Research
Source: Reuters
a claim that the retail giant failed to report suspicious prescription drug orders to the U.S. Drug Enforcement Administration (DEA). Chief U.S. District Judge Colm Connolly in Delaware in the order , opens new tab also dismissed a claim that Walmart pharmacists failed to document "red flags" associated with prescriptions. However, the judge allowed a claim that pharmacists dispensed prescriptions that the company's compliance personnel knew were invalid to go forward. A fourth claim, that pharmacists dispensed prescriptions that they themselves knew were invalid, was not part of Walmart's motion to dismiss and remains pending. Walmart said in a statement that the ruling "reinforces what we have said all along: the government's lawsuit is misguided and misapplies the law." It said the claim allowed by the judge "forces pharmacists and pharmacies into second-guessing DEA-approved doctors, and to come between patients and their doctors." The U.S. Department of Justice declin
Show less
Read more
Impact Snapshot
Event Time:
COR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
COR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
COR alerts
High impacting Cencora, Inc. news events
Weekly update
A roundup of the hottest topics
COR
News
- Cencora, Inc. (NYSE: COR) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.MarketBeat
- Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Robert W. Baird from $275.00 to $277.00. They now have an "outperform" rating on the stock.MarketBeat
- Pharma Wholesale and Distribution Market 10 Year Forecast Report 2024-2034: Global Market Set to Surpass the US$800 Billion Mark in 2024 [Yahoo! Finance]Yahoo! Finance
- Cencora Reports Fiscal 2024 Second Quarter ResultsBusiness Wire
- Cencora, Inc. (NYSE: COR) had its price target raised by analysts at Citigroup Inc. from $265.00 to $280.00. They now have a "buy" rating on the stock.MarketBeat
COR
Earnings
- 5/1/24 - Beat
COR
Sec Filings
- 5/1/24 - Form 10-Q
- 5/1/24 - Form 8-K
- 4/23/24 - Form 8-K
- COR's page on the SEC website